Skip to main content
< Back
About
About the conference
Latest updates
Organisers & Partners
App
Press room
Programme 19
Full programme
Tracks
Speakers 19
Keynote speakers
All speakers
Side events 19
Venue 19
About the venue
Location
Rooms
Subscribe
Cannabis
Sessions
Plenary session
Poster session
Big debate
Structured session
Workshop
Oral presentation session
Short communication session
Poster guided tour
Cannabis
Health consequences
Alcohol — Cannabis
Cannabis — Aetiology
Cannabis — Basic science
Cannabis — Policy
Cannabis — Public Health
Cannabis — Stimulants
Prevention — Cannabis
Wednesday, 23 October
10:50
Cannabis beyond psychosis
10:50
to
12:20
Central square 1 (C1)
Maria de las Mercedes Balcells
Definition of disorders
10:50
to
12:20
Networking zone 1 (N1)
Viktor Mravčík
Insights in biology
10:50
to
12:20
Insights zone 1 (I1)
Fernando Rodriguez de Fonseca
13:20
Nicotine harm reduction
13:20
to
14:50
Networking zone 4 (N4)
Ann McNeill
Modelling the impact of decriminalisation
13:20
to
14:50
Networking zone 1 (N1)
Rosalie Pacula
15:00
Prevention strategies
15:00
to
16:30
Insights zone 2 (I2)
Angelina Brotherhood
18:30
Smoking and health
18:30
to
19:30
Insights zone 1 (I1)
Robert West
Thursday, 24 October
09:00
Cannabis and causality — using multiple methods to unpick links between cannabis and neurobiology, cognition and mental health
09:00
to
10:30
Futures zone 3 (F3)
Suzanne Gage
Valentina Lorenzetti
10:50
Methods and approaches to inform drug policy and practice
10:50
to
12:20
Networking zone 4 (N4)
Márya Hynes
13:20
Regulating the low-THC cannabis market in Europe
13:20
to
14:50
Futures zone 1 (F1)
Davide Fortin
Cannabis — risks and responses
13:20
to
14:50
Networking zone 4 (N4)
Jennifer Price
15:00
Global changes in cannabis products
15:00
to
16:30
Main stage
Tom Freeman
Wayne Hall
Current trends and future challenges
The cannabis policy kaleidoscope
15:00
to
16:30
Central square 2 (C2)
Nicola Singleton
Drug markets
15:00
to
16:30
Insights zone 4 (I4)
Dirk Korf
16:50
New perspectives on cannabis use disorders and their treatment
16:50
to
18:20
Insights zone 4 (I4)
Tom Freeman
Valentina Lorenzetti
18:30
Cannabis labelling and health warnings: use and impacts
18:30
to
19:30
Insights zone 4 (I4)
Hanan Abramovici
Friday, 25 October
09:00
Studying the operation of new forms of cannabis supply
09:00
to
10:30
Central square 1 (C1)
Caitlin Hughes
Presentations
Plenary session
Poster session
Big debate
Structured session
Workshop
Oral presentation session
Short communication session
Poster guided tour
Wednesday, 23 October
10:50
Oral presentation
Impact of chronic cannabis use on physical health
10:50
to
12:20
Central square 1 (C1)
Hugo López-Pelayo
Oral presentation
Injury and cannabis use: Intentional and unintentional lesions
10:50
to
12:20
Central square 1 (C1)
Eugènia Campeny
Oral presentation
Cognitive functioning in cannabis users
10:50
to
12:20
Central square 1 (C1)
Oral presentation
Cerebellum and cannabis: research and clinical implications
10:50
to
12:20
Central square 1 (C1)
Chrysanthi Blithikioti
Oral presentation
Impact of cannabis use: integration of all research
10:50
to
12:20
Central square 1 (C1)
Laia Miquel
11:00
Oral presentation
Blunted ventral striatal responses to anticipated rewards foreshadow problematic drug use in novelty-seeking adolescents
11:00
to
11:15
Insights zone 1 (I1)
Christian Büchel
Oral presentation
Views about the disease and brain disease model of addiction: an international survey of addiction treatment providers in the USA, UK and Australia
11:00
to
11:15
Networking zone 1 (N1)
Anthony Barnett
11:15
Oral presentation
Epigenetics of drug addiction: a therapeutic opportunity and a transgenerational inheritance concern
11:15
to
11:30
Insights zone 1 (I1)
Felix Carvalho
Oral presentation
Reconsidering cannabis dependence
11:15
to
11:30
Networking zone 1 (N1)
Liz Temple
11:30
Oral presentation
An astrocyte-microglia crosstalk mediating neuroinflammation under exposure to psychostimulants
11:30
to
11:45
Insights zone 1 (I1)
Teresa Summavielle
Oral presentation
Agreement degree with the content of the Substance Addiction Consequences Scale items - The development of a new instrument.
11:30
to
11:45
Networking zone 1 (N1)
Paulo Seabra
11:45
Oral presentation
Acute psychotropic effects of 9-tetrahydrocannabinol (THC) associated with resting state brain function in the human insula: a pharmacological MRI study
11:45
to
12:00
Insights zone 1 (I1)
Matthijs Bossong
Oral presentation
Characterising people that demanded drug treatment in Catalonia: a cluster analysis
11:45
to
12:00
Networking zone 1 (N1)
Xavier Majó
12:00
Oral presentation
Synthetic cannabinoids 5F-PB22 and THJ-2201 promote neuronal differentiation in neureblastoma cells at biologically relevant concentrations
12:00
to
12:15
Insights zone 1 (I1)
João Pedro Silva
13:30
Short communication
Smokeless tobacco (snus) use and intergenerational social mobility among adolescents during 10 years
13:30
to
13:40
Networking zone 4 (N4)
Oral presentation
Models for the decriminalisation, depenalisation and diversion of illicit drug possession: an international realist review
13:30
to
13:45
Networking zone 1 (N1)
Caitlin Hughes
13:40
Short communication
Transitions in smoking and nicotine use from 2016 to 2017 among a UK cohort of past-year smokers
13:40
to
13:50
Networking zone 4 (N4)
Erikas Simonavicius
13:45
Oral presentation
To what extent will the drug-crime nexus remain after drug laws liberalisation? An examination of criminal charges among patients in treatment for cannabis use disorders and controls under varied drug policy regimes
13:45
to
14:00
Networking zone 1 (N1)
Anne Line Bretteville-Jensen
13:50
Short communication
Co-use and co-quitting: predicting motivation to quit tobacco and cannabis among further education college students in the UK
13:50
to
14:00
Networking zone 4 (N4)
Hannah Walsh
14:00
Short communication
Implementation of financial incentives for successful smoking cessation in real-life company settings
14:00
to
14:10
Networking zone 4 (N4)
Gera Nagelhout
Oral presentation
The law enforcement costs of de facto 'criminalising' drug possession: the Italian experience
14:00
to
14:15
Networking zone 1 (N1)
Davide Fortin
14:10
Short communication
Challenges in tobacco control in Serbia
14:10
to
14:20
Networking zone 4 (N4)
Biljana Kilibarda
14:15
Oral presentation
Introducing a new cannabis decriminalisation policy: The unintentional effects on cannabis perceptions and use among Israeli youth
14:15
to
14:30
Networking zone 1 (N1)
Yossi Harel-Fisch
15:10
Oral presentation
Recognising that behaviour is often automatic, contingent on environmental cues and with limited self-regulation: the potentials of environmental prevention
15:10
to
15:25
Insights zone 2 (I2)
Gregor Burkhart
15:25
Oral presentation
Invalidating adolescents' pro-cannabis opinions: a new tactic of prevention
15:25
to
15:40
Insights zone 2 (I2)
William Crano
15:40
Oral presentation
IDART- a national study on targeted injury prevention
15:40
to
15:55
Insights zone 2 (I2)
Benedicte Joergenrund
15:55
Oral presentation
Results of the EPOPS project: adaptation, implementation and evaluation of a programme empowering parents organisations for alcohol prevention in Spain and Portugal
15:55
to
16:10
Insights zone 2 (I2)
Cátia Magalhães
16:10
Oral presentation
Adolescents in need - study of the origin and demands of adolescents and youngsters arriving at West Lisbon CRI indicated prevention locals
16:10
to
16:25
Insights zone 2 (I2)
Isabel Prata Duarte
18:30
Oral presentation
Healthy recovery: results and reflections from a stepped wedge randomised controlled trial of a healthy lifestyle intervention within substance dependence treatment
18:30
to
18:45
Insights zone 1 (I1)
Peter Kelly
18:45
Oral presentation
Clearing the smoke: vaping cannabis among adolescents. Recent trends and implications
18:45
to
19:00
Insights zone 1 (I1)
Alexandra Kritikos
19:00
Oral presentation
Tobacco harm reduction: key themes
19:00
to
19:15
Insights zone 1 (I1)
Harry Shapiro
19:15
Oral presentation
A systematic review and network meta-analysis of the safety and effectiveness of smoking cessation medicines and electronic cigarettes
19:15
to
19:30
Insights zone 1 (I1)
Kyla Thomas
Thursday, 24 October
09:10
Oral presentation
Neurobiological changes predating and following cannabis use onset: findings from longitudinal neuroimaging studies
09:10
to
09:25
Futures zone 3 (F3)
Valentina Lorenzetti
09:25
Oral presentation
Transitions from use of cannabis to dependence, and comparisons with other substances
09:25
to
09:40
Futures zone 3 (F3)
Christina Marel
09:40
Oral presentation
Genetic liability for schizophrenia and patterns of tobacco and cannabis use in adolescence
09:40
to
09:55
Futures zone 3 (F3)
Oral presentation
Triangulating the evidence: exploring causality in the link between cannabis and mental health
09:40
to
09:55
Futures zone 3 (F3)
Suzanne Gage
11:00
Short communication
Quantitative and qualitative evidences for better gender-based prevention of adolescent addictive behaviours, with and without substance
11:00
to
11:10
Networking zone 4 (N4)
Patricia Gómez
11:10
Short communication
The European Web Survey on Drugs: patterns of use of new psychoactive substances in Belgium
11:10
to
11:20
Networking zone 4 (N4)
Lies Gremeaux
11:20
Short communication
From chronology to processes: combining biographical interview with episodic analysis in a life story
11:20
to
11:30
Networking zone 4 (N4)
Isabel María Herrera-Sánchez
11:30
Short communication
Coding multiple drug use in ICD-10 and ICD-11
11:30
to
11:40
Networking zone 4 (N4)
Espen Walderhaug
11:40
Short communication
The scientific portrayal of decriminalisation models for psychoactive substances: a scoping review
11:40
to
11:50
Networking zone 4 (N4)
Isabel María Herrera-Sánchez
Short communication
The scientific portrayal of decriminalisation models for psychoactive substances: a scoping review
11:40
to
11:50
Networking zone 4 (N4)
Daniela Filipa Ferreira
11:50
Short communication
The role of the juveniles in the structure and dynamics of the illegal drug market in the Republic of Croatia
11:50
to
12:00
Networking zone 4 (N4)
12:00
Short communication
Lifetime prevalence of drug use before imprisonment in Europe: results from a systematic literature review
12:00
to
12:10
Networking zone 4 (N4)
12:10
Short communication
Public participation in effective development of a regional drug strategy: experiences from the South East region of Ireland
12:10
to
12:20
Networking zone 4 (N4)
Michelle Foley
13:30
Short communication
Acute effects of cannabinoids on addiction endophenotypes are moderated by genes encoding the CNR1 receptor and FAAH enzyme
13:30
to
13:40
Networking zone 4 (N4)
Chandni Hindocha
Oral presentation
Low THC cannabis products in the EU
13:30
to
13:45
Futures zone 1 (F1)
Brendan Hughes
13:40
Short communication
Psychological aspects of cannabis use disorder: a review of the theory and implications for psychotherapy
13:40
to
13:50
Networking zone 4 (N4)
Daniel Feingold
13:45
Oral presentation
Low-THC cannabis: results of a survey among Swiss users
13:45
to
14:00
Futures zone 1 (F1)
Frank Zobel
13:50
Short communication
Intention to reduce cannabis use and help-seeking attitudes in Dutch frequent cannabis users.
13:50
to
14:00
Networking zone 4 (N4)
Marleen Olthof
14:00
Short communication
Perceptions of effectiveness and believability of pictorial and text-only health warning labels for cannabis products among Canadian youth.
14:00
to
14:10
Networking zone 4 (N4)
Cesar Leos-Toro
Oral presentation
Creating the light cannabis market in the EU: the Italian consumer experience
14:00
to
14:15
Futures zone 1 (F1)
Davide Fortin
14:10
Short communication
Cannabis use in early adulthood and later prescription of antipsychotics, mood stabilisers, antidepressants and anxiolytics.
14:10
to
14:20
Networking zone 4 (N4)
Eline Rognli
14:20
Short communication
Have chronic cannabis consumers developed tolerance to the residual effects of recent cannabis use?
14:20
to
14:30
Networking zone 4 (N4)
Raimondo Bruno
14:30
Short communication
Sociodemographic and educational characteristics of cannabis users attending outpatient treatment centres: implications for psychoeducational intervention
14:30
to
14:40
Networking zone 4 (N4)
Samuel Rueda
14:40
Short communication
Can cannabis use cause death in humans ?
14:40
to
14:50
Networking zone 4 (N4)
Mateja Jandl
15:10
Oral presentation
How have policies for legal medical and recreational cannabis shaped the development of new cannabis products?
15:10
to
15:25
Main stage
Wayne Hall
Oral presentation
Medical use of cannabis – a review of the regulatory frameworks and challenges
15:10
to
15:25
Central square 2 (C2)
Liesbeth Vandam
Oral presentation
Purity, adulteration and price of drugs bought on-line versus off-line in the Netherlands
15:10
to
15:25
Insights zone 4 (I4)
Daan van der Gouwe
15:25
Oral presentation
Changes in cannabis products during legal sales in Washington State
15:25
to
15:40
Main stage
Jonathan Caulkins
Oral presentation
Recreational cannabis legalisation in the Americas – design considerations and possible futures
15:25
to
15:40
Central square 2 (C2)
Beau Kilmer
15:40
Oral presentation
The International Cannabis Policy Study: comparing cannabis markets in Canada and US states with and without legal cannabis
15:40
to
15:55
Main stage
Elle Wadsworth
Oral presentation
CBD and other low-THC cannabis products, the latest health fad or serious drug policy challenge
15:40
to
15:55
Central square 2 (C2)
Brendan Hughes
Oral presentation
A descriptive analysis of the illicit supply of new psychoactive substances within and from China
15:40
to
15:55
Insights zone 4 (I4)
Minqi Zhao
15:55
Oral presentation
Changes in European cannabis resin: new evidence from THC and THC/CBD ratios in Denmark
15:55
to
16:10
Main stage
Kristine Rømer Thomsen
Oral presentation
Mobilising evidence-based secondary prevention for cannabis use in legalisation contexts: The Lower-Risk Cannabis Use Guidelines (LRCUG)
15:55
to
16:10
Central square 2 (C2)
Wayne Hall
Oral presentation
MDMA dosage in XTC tablets: size matters
15:55
to
16:10
Insights zone 4 (I4)
Ruben Vrolijk
16:10
Oral presentation
Health effects of new cannabis products in Europe
16:10
to
16:25
Main stage
Tom Freeman
Oral presentation
Key lessons for cannabis policy for the next decade
16:10
to
16:25
Central square 2 (C2)
Michael Farrell
Oral presentation
Understanding drug markets: results of the MARSTUP study
16:10
to
16:25
Insights zone 4 (I4)
Frank Zobel
17:00
Oral presentation
Cannabis use among people entering drug treatment. A growing phenomenon?
17:00
to
17:15
Insights zone 4 (I4)
Bruno Guarita
17:15
Oral presentation
Comparing adolescent and adult vulnerability to cannabis use problems
17:15
to
17:30
Insights zone 4 (I4)
Rachel Lees
17:30
Oral presentation
Cannabis and tobacco co-use: implications for addiction
17:30
to
17:45
Insights zone 4 (I4)
Chandni Hindocha
17:45
Oral presentation
Advances in the neurobiology of cannabis use disorders
17:45
to
18:00
Insights zone 4 (I4)
Valentina Lorenzetti
18:00
Oral presentation
Cannabidiol: a novel treatment for cannabis cessation?
18:00
to
18:15
Insights zone 4 (I4)
Tom Freeman
18:40
Oral presentation
Cannabis labelling and consumer understanding of THC levels and serving sizes.
18:40
to
18:55
Insights zone 4 (I4)
Samantha Goodman
18:55
Oral presentation
The impact of cannabis health warning labels on risk awareness and behaviour
18:55
to
19:10
Insights zone 4 (I4)
Adam Winstock
19:10
Oral presentation
The efficacy of health warnings and package branding on perceptions of cannabis products among youth and young adults.
19:10
to
19:25
Insights zone 4 (I4)
Cesar Leos-Toro
Friday, 25 October
09:10
Oral presentation
Presence and practices of cannabis social clubs within the European Union
09:10
to
09:25
Central square 1 (C1)
Mafalda Pardal
09:25
Oral presentation
Initial lessons and next steps for a public health approach to cannabis regulation in Canada
09:25
to
09:40
Central square 1 (C1)
Rebecca Jesseman
09:40
Oral presentation
Implementing cannabis regulation to achieve public health and safety goals in California – assessing the successes and challenges of the first year of regulation
09:40
to
09:55
Central square 1 (C1)
Jennifer Price
09:55
Oral presentation
Development of new measures of cannabis market exposure: a case study in Colorado
09:55
to
10:10
Central square 1 (C1)
Rosalie Pacula